Hypercoagulability of COVID‐19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis
By M. Panigada, N. Bottino, P. Tagliabue, G. Grasselli, C. Novembrino, V. Chantarangkul, A. Pesenti, F. Peyvandi, A. Tripodi. Journal of Thrombosis and Haemostasis, 2020
1,238 citations recorded by the source corpus.
The severe inflammatory state secondary to COVID‐19 leads to a severe derangement of hemostasis that has been recently described as a state of disseminated intravascular coagulation (DIC) and consumption coagulopathy, defined as decreased platelet count, increased fibrin(ogen) degradation products such as D‐dimer, as well as low fibrinogen.
Subfields: Critical Care and Intensive Care Medicine, Infectious Diseases, Surgery
View Paper: https://www.semanticscholar.org/paper/42ef5814b797b64ef7b7ddb56533575941932f3d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Infectious Diseases
Citations in the corpus
- Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza. (2020, background): “NIH Stroke Scale score, median (IQR) 16 (6-23)”